The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Integrated next-generation sequencing and patient-derived xenografts to personalized cancer treatment.
Elena Garralda
No relevant relationships to disclose
Antonio Calles
No relevant relationships to disclose
Fernando López-Ríos
No relevant relationships to disclose
Siân Jones
Employment or Leadership Position - Personal Genome Diagnostics
Lisa M. Kann
Employment or Leadership Position - Personal Genome Diagnostics
Samuel V. Angiuoli
Employment or Leadership Position - Personal Genome Diagnostics
Luis A. Diaz, Jr.
Employment or Leadership Position - Personal Genome Diagnostics (U)
Stock Ownership - Personal Genome Diagnostics
Victor E. Velculescu
Employment or Leadership Position - Personal Genome Diagnostics (U)
Stock Ownership - Personal Genome Diagnostics
Pedro P. López-Casas
No relevant relationships to disclose
Francesca Sarno
No relevant relationships to disclose
Raquel Martinez
No relevant relationships to disclose
Carlos Gomez-Martin
No relevant relationships to disclose
Esther Conde
No relevant relationships to disclose
Cristobal Belda-Iniesta
No relevant relationships to disclose
Alfonso Valencia
No relevant relationships to disclose
Manuel Hidalgo
No relevant relationships to disclose